CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Parschauer Karah Herdman Director | Sale | −12,888 | $12.99 | $167K | 32,183 |
| 2025-03-07 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Grant or award | +17,832 | 100,207 | ||
| 2025-03-07 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Grant or award · Performance Restricted Stock Units | +17,832 | 17,832 | ||
| 2025-03-07 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +25,407 | 25,407 | ||
| 2025-03-07 | Beaver Sandra Chief Financial Officer | Grant or award | +35,663 | 182,579 | ||
| 2025-03-07 | Beaver Sandra Chief Financial Officer | Grant or award · Performance Restricted Stock Units | +35,663 | 35,663 | ||
| 2025-03-07 | Beaver Sandra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,813 | 50,813 | ||
| 2025-03-07 | MOATAZEDI DAVID See Remarks | Grant or award | +95,399 | 618,246 | ||
| 2025-03-07 | MOATAZEDI DAVID See Remarks | Grant or award · Performance Restricted Stock Units | +190,799 | 190,799 | ||
| 2025-03-07 | MOATAZEDI DAVID See Remarks | Grant or award · Stock Option (Right to Buy) | +135,925 | 135,925 | ||
| 2025-03-07 | Avelar Rui See Remarks | Grant or award | +23,776 | 390,371 | ||
| 2025-03-07 | Avelar Rui See Remarks | Grant or award · Performance Restricted Stock Units | +23,776 | 23,776 | ||
| 2025-03-07 | Avelar Rui See Remarks | Grant or award · Stock Option (Right to Buy) | +33,875 | 33,875 | ||
| 2025-03-07 | BLANK SIMONE Director | Grant or award | +7,364 | 77,111 | ||
| 2025-03-07 | BLANK SIMONE Director | Grant or award · Stock Option (Right to Buy) | +11,146 | 11,146 | ||
| 2025-03-07 | GILL DAVID N Director | Grant or award | +7,364 | 41,328 | ||
| 2025-03-07 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +11,146 | 11,146 | ||
| 2025-03-07 | Stewart Brady Director | Grant or award | +7,364 | 58,629 | ||
| 2025-03-07 | Stewart Brady Director | Grant or award · Stock Option (Right to Buy) | +11,146 | 11,146 | ||
| 2025-03-07 | White Albert G III Director | Grant or award | +7,364 | 30,378 |
Page 3 of 16 · 303 trades